Information:
Fel:
ID
14780
Beskrivning
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01); ODM derived from: https://clinicaltrials.gov/show/NCT00520637
Länk
https://clinicaltrials.gov/show/NCT00520637
Nyckelord
Versioner (1)
- 2016-04-27 2016-04-27 -
Uppladdad den
27 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Advanced Solid Tumors NCT00520637
Eligibility Advanced Solid Tumors NCT00520637
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Solid Tumors NCT00520637
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
solid tumor or lymphoma
Item
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0024299 (UMLS CUI [2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
ecog
Item
score of 0 to 2 on the ecog performance scale
boolean
C1520224 (UMLS CUI [1])
medical illness
Item
concurrent serious medical illness
boolean
C0262926 (UMLS CUI [1])
central nervous system (cns) tumor involvement
Item
known, clinically suspected, or history of central nervous system (cns) tumor involvement
boolean
C0085136 (UMLS CUI [1])
active diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
coagulation disorder
Item
known history of coagulation disorder
boolean
C0005779 (UMLS CUI [1])
cytochrome p450 3a4
Item
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
boolean
C3830625 (UMLS CUI [1])
ketoconazole
Item
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
boolean
C0022625 (UMLS CUI [1])
chemotherapy, immunotherapy
Item
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C0021083 (UMLS CUI [2])